News Choose Year All Years 2024 (6) 2023 (2) 2022 (2) 2021 (1) Search Press Releases Found 11 Results November 18, 2024 Rectify Pharma Presents Preclinical Data Supporting Development of Lead Candidate RTY-694 at The Liver Meeting® 2024 Read More November 12, 2024 Rectify Pharma to Host Virtual R&D Event on RTY-694 for Primary Sclerosing Cholangitis and Other Hepatobiliary Diseases on November 21, 2024 Read More October 22, 2024 Rectify Pharma Announces Positive Functional Modulator RTY-694 as Development Candidate for Primary Sclerosing Cholangitis Read More October 17, 2024 Rectify Pharmaceuticals to Present New Preclinical Data at The American Association for the Study of Liver Diseases Annual Meeting Read More September 3, 2024 Rectify Pharmaceuticals Appoints Pol Boudes as Chief Medical Officer Read More July 15, 2024 Rectify Pharmaceuticals Appoints Bharat Reddy as Chief Business Officer Read More April 25, 2023 Rectify Pharmaceuticals Appoints Sachiyo Minegishi as Chief Operating Officer Read More February 14, 2023 Rectify Pharmaceuticals Expands Clinical Drug Development Expertise with Board and SAB Appointments Read More 12»
Read More